CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank86
5Y CAGR+1.2%
Studio
Year-over-Year Change

Price-to-book ratio

5Y CAGR
+1.2%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
20253.90+142.1%
20241.61+253.5%
2023-1.05+79.0%
2022-4.99-205.9%
20214.71+28.0%
20203.68+41.6%
20192.60+44.3%
20181.80-5.1%
20171.90-19.1%
20162.35-